• Tofacitinib (CP-690550): Mechanistic Insights for Advanced I

  2026-05-31

  Explore how Tofacitinib (CP-690550) uniquely modulates immune and mitochondrial pathways in research. This article provides deep mechanistic analysis and protocol guidance for immune modulation studies.

• AZ505, a Potent and Selective SMYD2 Inhibitor: Practical Lab

  2026-05-30

  This article provides scenario-driven guidance for using AZ505, a potent and selective SMYD2 inhibitor (SKU B1255), to address reproducibility, specificity, and workflow challenges in biomedical research. Drawing on peer-reviewed data and validated protocols, we demonstrate how AZ505 supports reliable cell viability, proliferation, and epigenetic regulation studies.

• PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide):

  2026-05-29

  This article explores practical laboratory challenges in inflammation and sepsis research, highlighting how PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide), SKU C4074, delivers reproducible, literature-backed solutions for cell viability and immune modulation assays. Evidence-based scenario analyses demonstrate PPM-18’s utility and workflow advantages for biomedical scientists.

• Actin–Myosin II Network Regulates DEV Proliferation via VP26

  2026-05-29

  This study uses proteomic screening to reveal that the duck enteritis virus (DEV) protein VP26 targets host actin–myosin II cytoskeletal components, specifically MYH9, to facilitate viral replication. The findings demonstrate that disrupting actin polymerization significantly reduces DEV titers, highlighting the cytoskeleton's essential role in viral pathogenesis and providing actionable insights for cell and virology research.

• Repurposing Clinically Safe Drugs to Modulate DNA Repair Pat

  2026-05-28

  This study systematically screened over 7,000 FDA-approved drugs to identify compounds that modulate DNA double-strand break (DSB) repair pathways in human iPSCs undergoing CRISPR editing. The findings reveal new opportunities to guide DNA repair outcomes, inform synthetic lethality strategies, and expand precision medicine approaches in genome engineering.

• Y-27632 dihydrochloride: Reliable ROCK Inhibitor for Cell As

  2026-05-28

  This evidence-driven article examines practical laboratory challenges in cell viability, proliferation, and cytotoxicity assays, highlighting how Y-27632 dihydrochloride (SKU A3008) from APExBIO offers validated, reproducible solutions. Realistic scenarios, vendor comparison, and protocol guidance are provided to help researchers optimize workflows using this highly selective ROCK inhibitor.

• Revolutionizing Apoptosis Research: Caspase-3 Assays in Tran

  2026-05-27

  Explore the mechanistic underpinnings and translational significance of DEVD-dependent caspase-3 activity detection in apoptosis research, with strategic guidance for leveraging advanced fluorometric assays—anchored by the latest evidence on caspase crosstalk in cancer therapy and practical insights into experimental design.

• Advancing Liver Injury Models: Anti-ROR1 Antibody (Ziloverta

  2026-05-27

  Explore the strategic integration of Anti-ROR1 Antibody (Zilovertamab) in the next generation of liver injury and oncology research. This thought-leadership article dissects the mechanistic rationale behind targeting Wnt5a-induced ROR1 signaling, presents experimental validation strategies, and offers actionable guidance for translational scientists seeking to bridge complex disease models with clinically-relevant assays.

• Anti-ROR1 Antibody (Zilovertamab): Applied Cancer Research W

  2026-05-26

  Unlock precise Wnt5a-induced ROR1 signaling inhibition in cancer and liver injury models with Anti-ROR1 Antibody (Zilovertamab). This guide details practical workflows, troubleshooting strategies, and innovations that set this APExBIO reagent apart in functional and translational research.

• Necrostatin-1 (Nec-1): Reliable RIP1 Kinase Inhibitor for Ne

  2026-05-26

  This article provides an evidence-driven guide for using Necrostatin-1 (Nec-1), (R)-5-([7-chloro-1H-indol-3-yl]methyl)-3-methylimidazolidine-2,4-dione (SKU A4213) in necroptosis and cell death research. Drawing on published studies and practical lab scenarios, it demonstrates how SKU A4213 addresses reproducibility, sensitivity, and compatibility challenges in necroptosis assays. Readers will find actionable protocol insights and vendor selection guidance for optimizing experimental outcomes.

• LGK-974 (Porcupine Inhibitor): Deep Mechanistic Insights for

  2026-05-25

  Explore how LGK-974, a premier PORCN inhibitor, enables advanced, mechanism-driven modulation of the Wnt signaling pathway. This article delivers a unique perspective by connecting developmental biology insights to assay optimization and cancer research applications.

• Elobixibat Hydrate: Translational Leverage in Gut-Metabolic

  2026-05-25

  This article explores how Elobixibat hydrate, a selective ileal bile acid transporter inhibitor, is reshaping translational research and clinical strategies for chronic idiopathic constipation and metabolic disorders. Integrating mechanistic insight, clinical benchmarking, and experimental guidance, it highlights new frontiers for gut-metabolic therapeutics and offers practical protocol parameters for researchers.

• Dextromethorphan Hydrobromide in Neuroprotection Research

  2026-05-24

  Dextromethorphan hydrobromide is a versatile NMDA receptor antagonist widely used to dissect mechanisms of neuroprotection and excitotoxicity inhibition in preclinical models. This article delivers actionable workflows, troubleshooting tips, and experimental insights that maximize reproducibility and data quality when leveraging this compound in neuroscience research.

• Y-27632 Dihydrochloride: ROCK Inhibitor Workflows & Optimiza

  2026-05-23

  Y-27632 dihydrochloride is a gold-standard, selective ROCK inhibitor, enabling precision in stem cell viability, cytoskeletal modulation, and tumor invasion suppression. This guide translates bench research advances and reference study innovations into actionable workflows, troubleshooting strategies, and protocol enhancements for diverse experimental systems.

• Jasplakinolide: Actin Polymerization Inducer for Precision C

  2026-05-22

  Jasplakinolide stands out as a high-potency actin polymerization inducer, empowering researchers to dissect cytoskeletal dynamics with unmatched precision. This guide offers hands-on protocol enhancements, troubleshooting insights, and cross-referenced resources to maximize success in actin cytoskeleton studies.

447 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page